CANCER CYTOPATHOLOGY

简称 CANCER CYTOPATHOL ·UNITED STATES ·出版周期 Bimonthly ·年均收录 91 篇

3.2

最新影响因子

18.20%

自引率

约25%

投稿难度

平均1月

审稿周期

期刊简介

CANCER CYTOPATHOLOGY是一本专注于肿瘤细胞病理学研究的国际期刊，ISSN号为1934-662X，由美国Wiley-Blackwell出版商出版，出版地为美国，出版周期为月刊。该期刊被SCI收录，2022年影响因子为3.4，属于中科院医学大类四区，非开放获取（OA）期刊。其发文特点集中于肿瘤诊断、细胞病理学技术、分子病理学及临床病理学应用等领域，尤其关注癌症早期诊断和精准医疗相关研究。杂志质量中等，审稿周期相对较短，但近年影响因子波动较小，竞争度不高，需注意投稿时研究创新性与临床实用性的平衡，以避免因内容重复性较高而导致拒稿风险。

影响因子趋势

近期发表

New research points to growing potential for detecting minimal residual disease 2026-09-01

10.1002/cncy.v134.9 2026-08-06

Spotlight: Rising stars in cytology 2026-08-24

Assessment of atypical glandular cell interpretation in Pap tests using the Hologic Genius Digital Diagnostics System 2026-08-20

Diagnostic utility of high‐risk HPV polymerase chain reaction–based testing in head and neck FNA specimens with indeterminate cytomorphology 2026-08-20

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance 2026-08-18

Interobserver variation among cytopathologists in the evaluation of oncocytic cell‐predominant thyroid FNA cytology: A validation study of 173 cases with surgical follow‐up and correlation with molecular testing 2026-08-18

Spotlight: Rising stars in cytology 2026-08-14

Leveraging large language models to enhance cytopathology: Opportunities, challenges, and future directions; a practical review from the ASC Clinical Practice Committee 2026-08-12

Harmonizing biomarker testing in NSCLC: The critical role of cytopathology in delivering comprehensive biomarker testing for patients with NSCLC 2026-08-12